Cellular metabolism of myeloid cells in sepsis

被引:82
|
作者
Arts, Rob J. W.
Gresnigt, Mark S.
Joosten, Leo A. B.
Netea, Mihai G.
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands
基金
欧洲研究理事会;
关键词
glycolysis; epigenetics; endotoxin; glucose; fatty acid; FATTY-ACID OXIDATION; NUCLEAR HORMONE-RECEPTORS; CRITICALLY-ILL PATIENTS; NF-KAPPA-B; BLOOD MONONUCLEAR-CELLS; INHIBITS HMGB1 RELEASE; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; RAW; 264.7; CELLS; AMINO-ACID;
D O I
10.1189/jlb.4MR0216-066R
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In recent years, it has become appreciated that immune cells have different metabolic profiles depending on their activation status. During sepsis, circulating leukocytes go through a hyperinflammatory state, which can be accompanied or followed by defective antimicrobial defenses (also described as immune tolerance or paralysis). In this review, the modulation of different cellular metabolic pathways during sepsis in monocytes and macrophages will be discussed. Glycolysis is studied extensively in sepsis and is up-regulated in hyperinflammatory cells, whereas in immune tolerance, it is often down-regulated. Few data are available on other metabolic pathways in immune cells from patients with sepsis. The pentose phosphate pathway is up-regulated during acute hyperinflammatory responses, whereas fatty acid beta-oxidation is increased later during sepsis and is associated with an anti-inflammatory (M2) phenotype of macrophages. Within the amino acid metabolism we will discuss the most studiedmetabolites. Collectively, these data argue that exploration of the immunometabolic pathways in sepsis is an important area of research, and the targeting of metabolic pathways may represent a promising novel strategy as a therapy of sepsis.
引用
收藏
页码:151 / 164
页数:14
相关论文
共 50 条
  • [31] CELLULAR EXPRESSION OF CP-10 IN MURINE MYELOID CELLS
    IISMAA, SE
    HU, SP
    KOCHER, M
    GECZY, CL
    JOURNAL OF LEUKOCYTE BIOLOGY, 1993, : 49 - 49
  • [32] Cellular injury in sepsis
    Kantrow, SP
    Summer, WR
    CRITICAL CARE MEDICINE, 2000, 28 (10) : 3569 - 3570
  • [33] Cellular Dysfunction in Sepsis
    Singer, Mervyn
    CLINICS IN CHEST MEDICINE, 2008, 29 (04) : 655 - +
  • [34] Cellular processes in sepsis
    Rudiger, Alain
    Stotz, Martin
    Singer, Mervyn
    SWISS MEDICAL WEEKLY, 2008, 138 (43-44) : 629 - 634
  • [35] The cellular response in sepsis
    Pajkrt, D
    vanDeventer, SJH
    PATHOLOGY OF SEPTIC SHOCK, 1996, 216 : 119 - 132
  • [36] CELLULAR DYSFUNCTION IN SEPSIS
    HARKEMA, JM
    DEAN, RE
    STEPHAN, RN
    CHAUDRY, IH
    JOURNAL OF CRITICAL CARE, 1990, 5 (01) : 62 - 69
  • [37] S100A9-INDUCED REPROGRAMMING OF MYELOID CELLS DURING SEPSIS
    Alkhateeb, Tuqa
    Bah, Isatou
    Kumbhare, Ajinkya
    McCall, Charles
    El Gazzar, Mohamed
    CRITICAL CARE MEDICINE, 2020, 48
  • [38] Dietary modification of myeloid-derived suppressor cells (MDSC) activity in sepsis
    Gautier, Juan B. Ochoa
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (12)
  • [39] Myeloid-derived suppressor cells in secondary sepsis: Is there an association with lethal outcome?
    Udovicic, Ivo
    Surbatovic, Maja
    Rondovic, Goran
    Stanojevic, Ivan
    Zeba, Snjezana
    Djordjevic, Dragan
    Popadic, Ana
    Milosavljevic, Snezana
    Stankovic, Nikola
    Abazovic, Dzihan
    Vojvodic, Danilo
    VOJNOSANITETSKI PREGLED, 2020, 77 (08) : 773 - 783
  • [40] INCREASED CIRCULATING MYELOID DERIVED SUPPRESSOR CELLS AND PICS IN SEVERE TRAUMA AND SEPSIS
    Vanzant, E.
    Gentile, L. F.
    Lanz, J.
    Davis, R.
    Nacionales, D.
    Ungaro, R.
    Cuenca, A.
    Moldawer, L.
    Bihorac, A.
    McKinley, B. A.
    Moore, F. A.
    Efron, P. A.
    SHOCK, 2013, 39 : 74 - 74